Kamada Ltd. (KMDA)
8.08
+0.30
(+3.92%)
USD |
NASDAQ |
Oct 09, 16:00
8.07
-0.01
(-0.12%)
After-Hours: 20:00
Kamada Market Cap : 466.17M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 466.17M |
| October 08, 2026 | 448.57M |
| October 07, 2026 | 455.21M |
| October 06, 2026 | 467.90M |
| October 05, 2026 | 461.55M |
| October 02, 2026 | 479.44M |
| October 01, 2026 | 473.09M |
| September 30, 2026 | 488.09M |
| September 29, 2026 | 501.65M |
| September 28, 2026 | 497.32M |
| September 25, 2026 | 503.09M |
| September 24, 2026 | 509.44M |
| September 23, 2026 | 505.98M |
| September 22, 2026 | 511.75M |
| September 21, 2026 | 504.25M |
| September 18, 2026 | 510.59M |
| September 17, 2026 | 500.21M |
| September 16, 2026 | 472.52M |
| September 15, 2026 | 466.75M |
| September 14, 2026 | 479.44M |
| September 11, 2026 | 456.94M |
| September 10, 2026 | 460.98M |
| September 09, 2026 | 473.67M |
| September 08, 2026 | 478.29M |
| September 04, 2026 | 492.71M |
| Date | Value |
|---|---|
| September 03, 2026 | 477.13M |
| September 02, 2026 | 484.63M |
| September 01, 2026 | 483.48M |
| August 31, 2026 | 474.82M |
| August 28, 2026 | 478.29M |
| August 27, 2026 | 476.55M |
| August 26, 2026 | 483.48M |
| August 25, 2026 | 497.90M |
| August 24, 2026 | 486.36M |
| August 21, 2026 | 475.40M |
| August 20, 2026 | 462.71M |
| August 19, 2026 | 455.21M |
| August 18, 2026 | 455.21M |
| August 17, 2026 | 447.71M |
| August 14, 2026 | 437.32M |
| August 13, 2026 | 418.86M |
| August 12, 2026 | 396.94M |
| August 11, 2026 | 409.05M |
| August 10, 2026 | 411.94M |
| August 07, 2026 | 419.44M |
| August 06, 2026 | 411.94M |
| August 05, 2026 | 414.25M |
| August 04, 2026 | 423.48M |
| August 03, 2026 | 417.13M |
| July 31, 2026 | 411.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 9.680M |
| XTL Biopharmaceuticals Ltd. | 4.684M |
| Can-Fite BioPharma Ltd. | 4.071M |
| Eocene Ltd. | 3.545M |
| Revium Recovery, Inc. | 86.84M |
Market Cap Related Metrics
| PE Ratio | 21.17 |
| PS Ratio | 2.474 |
| PEG Ratio | 1.370 |
| Price to Book Value | 1.729 |
| Price to Free Cash Flow | 17.18 |
| Price | 8.08 |
| Earnings Yield | 4.72% |
| PEGY Ratio | 1.025 |
| Operating PE Ratio | 17.06 |
| Normalized PE Ratio | 20.63 |